Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Taieb, D."" wg kryterium: Autor


Tytuł :
To what extent has the reorganization of nuclear medicine activities during the COVID-19 pandemic fulfilled medical ethics?
Autorzy :
Gonzalez S; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France. .; Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France. .
Taïeb D; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France.; Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.; Aix-Marseille Université INSERM, UMR1068, CRCM, Marseille, France.
Guedj E; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France.; Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.; Institut Fresnel, Aix-Marseille Université, CRCM, Ecole Centrale Marseille, UMR 7249, Marseille, France.
Le Coz P; Espace Ethique Méditerranéen, Timone University Hospital, UMR 7268 ADéS, Aix-Marseille University-EFS-CNRS, 13385, Marseille, France.
Cammilleri S; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France.; Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.; Institut Fresnel, Aix-Marseille Université, CRCM, Ecole Centrale Marseille, UMR 7249, Marseille, France.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Jan; Vol. 48 (1), pp. 3-5. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Letter
MeSH Terms :
Ethics, Medical*
COVID-19/*epidemiology
Hospital Restructuring/*ethics
Nuclear Medicine Department, Hospital/*organization & administration
Humans
Opinia redakcyjna
Tytuł :
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-Dotatate: an analysis of the NETTER-1 study.
Autorzy :
Strosberg J; Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, Tampa, FL, USA. .
Kunz PL; Department of Medicine - Med/Oncology, Stanford University Medical Center, Stanford, CA, USA.
Hendifar A; Department of Internal Medicine/Hematology/Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Yao J; Department of Gastrointestinal Medicinal Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bushnell D; Department of Radiology, The University of Iowa, Iowa City, IA, USA.
Kulke MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Baum RP; Department of Nuclear Medicine, Zentralklinik Bad Berka, Bad Berka, Germany.
Caplin M; Department of Gastroenterology and Tumour Neuroendocrinology, Royal Free Hospital, London, UK.
Ruszniewski P; Division of Gastroenterology and Pancreatology, Hôpital Beaujon, Clichy, France.
Delpassand E; Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, Houston, TX, USA.
Hobday T; Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Verslype C; Department of Hepatology, University Hospitals and KU Leuven, Leuven, Belgium.
Benson A; Hematology Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
Srirajaskanthan R; Department of Gastroenterology and General Internal Medicine, King's College Hospital - NHS Foundation Trust, London, UK.
Pavel M; Division of Hepatology and Gastroenterology, Charite-Universitätsmedizin Berlin, Berlin, Germany.
Mora J; Department of Nuclear Medicine, Hospital Universitari de Bellvitge, Barcelona, Spain.
Berlin J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Grande E; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
Reed N; Department of Medical Oncology, Beatson Oncology Centre, Glasgow, UK.
Seregni E; Department of Nuclear Medicine Therapy and Endocrinology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.
Paganelli G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Severi S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Morse M; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Metz DC; GI Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Ansquer C; Nuclear Medicine Department, Hôtel Dieu, University Hospital, Nantes, France.
Courbon F; Medical Imaging, Oncology University Institut Claudius Regaud, Toulouse, France.
Al-Nahhas A; Division of Imaging and Interventional Radiology, Imperial College London, London, UK.
Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France.
Giammarile F; Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Taïeb D; Department of Nuclear Medicine, Hôpital de la Timone, Marseille, France.
Mittra E; Department of Nuclear Medicine, Oregon Health & Science University, Portland, OR, USA.
Wolin E; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
O'Dorisio TM; Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA.
Lebtahi R; Department of Nuclear Medicine, Royal Free Hospital, London, UK.
Deroose CM; Nuclear Medicine Department, University Hospitals and KU Leuven, Leuven, Belgium.
Grana CM; Division of Nuclear Medicine, Istituto Europeo di Oncologia, Milan, Italy.
Bodei L; Department of Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Öberg K; Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
Polack BD; Department of Medical Information, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
He B; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Mariani MF; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Gericke G; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Santoro P; Department of Clinical Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Erion JL; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Ravasi L; Research and Development, Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Krenning E; Department of Nuclear Medicine, Cyclotron Rotterdam BV, Erasmus University Medical Center, Rotterdam, Netherlands.
Pokaż więcej
Corporate Authors :
NETTER-1 study group
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Sep; Vol. 47 (10), pp. 2372-2382. Date of Electronic Publication: 2020 Mar 02.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Liver Neoplasms*/radiotherapy
Neuroendocrine Tumors*/radiotherapy
Organometallic Compounds*/therapeutic use
Alkaline Phosphatase ; Humans ; Octreotide/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Good clinical practice recommendations for the use of PET/CT in oncology.
Autorzy :
Salaün PY; Department of Nuclear Medicine, University Hospital of Brest, 5 Avenue Foch, 29609, Brest, France. .
Abgral R; Department of Nuclear Medicine, University Hospital of Brest, 5 Avenue Foch, 29609, Brest, France.
Malard O; Head and Neck, University Hospital of Nantes, Nantes, France.
Querellou-Lefranc S; Department of Nuclear Medicine, University Hospital of Brest, 5 Avenue Foch, 29609, Brest, France.
Quere G; Thoracic Oncology, University Hospital of Brest, Brest, France.
Wartski M; Nuclear Medicine, Cochin Hospital AP-HP, Paris, France.
Coriat R; Gastroenterology, Cochin Hospital AP-HP, Paris, France.
Hindie E; Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France.
Taieb D; Nuclear Medicine, AP-HM, Marseille, France.
Tabarin A; Endocrinology, University Hospital of Bordeaux, Bordeaux, France.
Girard A; Nuclear Medicine, Eugène Marquis Center, Rennes, France.
Grellier JF; Nuclear Medicine, Foch Hospital, Paris, France.
Brenot-Rossi I; Nuclear Medicine, Paoli-Calmettes Institute, Marseille, France.
Groheux D; Nuclear Medicine, Hopital Saint Louis AP-HP, Paris, France.
Rousseau C; Nuclear Medicine, Ouest Cancer Institute, Nantes, France.
Deandreis D; Nuclear Medicine, Department of Medical Sciences, Citta della Salute e della Scienza, Turin, Italy.
Alberini JL; Nuclear Medicine, Georges-François Leclerc center - François Mitterrand University Hospital, Dijon, France.
Bodet-Milin C; Nuclear Medicine, University Hospital of Nantes, Nantes, France.
Itti E; Nuclear Medicine, Henri Mondor Hospital AP-HP, Paris, France.
Casasnovas O; Hematology, University Hospital Le Bocage, Dijon, France.
Kraeber-Bodere F; Nuclear Medicine, Ouest Cancer Institute, Nantes, France.; Nuclear Medicine, University Hospital of Nantes, Nantes, France.
Moreau P; Hematology, University Hospital of Nantes, Nantes, France.
Philip A; Centre du traitement de la douleur, CHRU de Brest, Brest, France.
Balleyguier C; Radiology, Gustave Roussy Institute, Villejuif, France.
Luciani A; Radiology, Henri Mondor Hospital AP-HP, Paris, France.
Cachin F; Nuclear Medicine, Jean Perrin Cancer Institute, Clermont-Ferrand, France.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Jan; Vol. 47 (1), pp. 28-50. Date of Electronic Publication: 2019 Oct 21.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasms*/diagnostic imaging
Nuclear Medicine*
Humans ; Medical Oncology ; Positron Emission Tomography Computed Tomography
Czasopismo naukowe
Tytuł :
Current experts' views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma.
Autorzy :
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, 264 rue Saint-Pierre, 13005, Marseille Cedex 05, France. david.taieb@ap-hm.fr.
Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892-1109, USA. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Oct; Vol. 46 (11), pp. 2223-2224. Date of Electronic Publication: 2019 Jul 22.
Typ publikacji :
Editorial
MeSH Terms :
Adrenal Gland Neoplasms/*diagnostic imaging
Nuclear Medicine/*methods
Paraganglioma/*diagnostic imaging
Pheochromocytoma/*diagnostic imaging
Precision Medicine/*methods
Biomarkers ; Decision Support Systems, Clinical ; Diagnostic Imaging ; Evidence-Based Medicine ; Humans ; Mutation ; Phenotype ; Practice Guidelines as Topic ; Radiopharmaceuticals
Opinia redakcyjna
Tytuł :
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.
Autorzy :
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, 264 rue Saint-Pierre, 13005, Marseille Cedex 05, France. david.taieb@ap-hm.fr.
Hicks RJ; Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Hindié E; Department of Nuclear Medicine, Hôpital Haut-Lévêque, Bordeaux University Hospitals, Pessac, France.
Guillet BA; Department of Radiopharmacy, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Avram A; Nuclear Medicine/Radiology, University of Michigan, Ann Arbor, MI, USA.
Ghedini P; Nuclear Medicine Unit, Medicina Nucleare Metropolitana, University Hospital S.Orsola-Malpighi, Bologna, Italy.
Timmers HJ; Department of Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Scott AT; John Hopkins Hospital, Baltimore, MD, USA.
Elojeimy S; Department of Radiology, University of New Mexico, Albuquerque, NM, USA.
Rubello D; Department of Nuclear Medicine, Radiology, Neuroradiology, Medical Physics, Clinical Laboratory, Microbiology, Pathology, Transfusional Medicine, Santa Maria della Misericordia Hospital, Rovigo, Italy.
Virgolini IJ; Department of Nuclear Medicine, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Fanti S; Nuclear Medicine Unit, Medicina Nucleare Metropolitana, University Hospital S.Orsola-Malpighi, Bologna, Italy.
Balogova S; Department of Nuclear Medicine, Comenius University and St. Elisabeth Oncology Institute, Heydukova 10, 81250, Bratislava, Slovakia.; Department of Nuclear Medicine, Hôpital Tenon Assistance Publique-Hôpitaux de Paris and Sorbonne University, Paris, France.
Pandit-Taskar N; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pacak K; Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Sep; Vol. 46 (10), pp. 2112-2137. Date of Electronic Publication: 2019 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Practice Guidelines as Topic*
Adrenal Gland Neoplasms/*diagnostic imaging
Nuclear Medicine/*standards
Pheochromocytoma/*diagnostic imaging
Positron-Emission Tomography/*standards
Adrenal Gland Neoplasms/radiotherapy ; European Union ; Humans ; Iodine Radioisotopes/therapeutic use ; Nuclear Medicine/organization & administration ; Pheochromocytoma/radiotherapy ; Positron-Emission Tomography/methods ; Radiopharmaceuticals/pharmacokinetics ; Radiopharmaceuticals/standards ; Radiopharmaceuticals/therapeutic use ; Societies, Medical/standards ; Somatostatin/analogs & derivatives
Czasopismo naukowe
Tytuł :
Early F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma.
Autorzy :
Leroy-Freschini B; Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.
Amodru V; Endocrinology, Diabetes and Metabolic Disorders, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Addeo P; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France.
Sebag F; Endocrine Surgery, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Vix M; General, Digestive, and Endocrine Surgery, IRCAD-IHU, University of Strasbourg, Strasbourg, France.
Brunaud L; Endocrine and General Surgery, University Hospital of Nancy, Nancy, France.
Klein M; Endocrinology, University Hospital of Nancy, Nancy, France.
Bahougne T; Diabetology, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.
Bachellier P; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France.
Castinetti F; Endocrinology, Diabetes and Metabolic Disorders, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Goichot B; Internal Medicine, Diabetes and Metabolic Disorders, University Hospitals of Strasbourg, Strasbourg University, Strasbourg, France.
Chevalier E; Nuclear Medicine, University Hospital of Nancy, Nancy, France.
Taieb D; Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.
Imperiale A; Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France. .; ICube, UMR 7357 Strasbourg University / CNRS & FMTS, Faculty of Medicine of Strasbourg, Strasbourg, France. .; Department of Nuclear Medicine, Hautepierre University Hospital, 1, Avenue Molière, 67098, Strasbourg Cedex, France. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Mar; Vol. 46 (3), pp. 686-695. Date of Electronic Publication: 2019 Jan 07.
Typ publikacji :
Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Carbidopa/*pharmacology
Dihydroxyphenylalanine/*analogs & derivatives
Insulinoma/*diagnostic imaging
Pancreatic Neoplasms/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Insulin/metabolism ; Insulinoma/metabolism ; Male ; Middle Aged ; Pancreatic Neoplasms/metabolism ; Retrospective Studies ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy.
Autorzy :
Guedj E; Service de Médecine Nucléaire, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France. .; CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Aix-Marseille Université, Marseille, France. .; CERIMED, Aix-Marseille Université, Marseille, France. .
Graillon T; Service de Neurochirurgie, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.; CNRS, UMR7286, CRN2M, Aix-Marseille Université, Marseille, France.
Chinot O; Service de Neuro-Oncologie, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
Taieb D; Service de Médecine Nucléaire, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.; CERIMED, Aix-Marseille Université, Marseille, France.; Inserm, U1068-CNRS 7258, Cancer Research Center of Marseille, Aix-Marseille Université, Marseille, France.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Mar; Vol. 46 (3), pp. 537-538. Date of Electronic Publication: 2018 Dec 14.
Typ publikacji :
Letter
MeSH Terms :
Meningeal Neoplasms/*pathology
Meningeal Neoplasms/*radiotherapy
Meningioma/*pathology
Meningioma/*radiotherapy
Receptors, Peptide/*metabolism
Humans ; Meningeal Neoplasms/metabolism ; Meningioma/metabolism ; Recurrence
Opinia redakcyjna
Tytuł :
Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?
Autorzy :
Giovanella L; Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500, Bellinzona, Switzerland. .
Avram AM; Nuclear Medicine/Radiology, University of Michigan, Ann Arbor, USA.
Clerc J; Department of Nuclear Medicine, Cochin University Hospital, René Descartes University, Paris, France.
Hindié E; Nuclear Medicine, Haut-Lévêque University Hospital, Bordeaux, France.
Taïeb D; Department of Nuclear Medicine, European Center for Research in Medical Imaging, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Verburg FA; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Nov; Vol. 45 (12), pp. 2155-2158. Date of Electronic Publication: 2018 Jul 30.
Typ publikacji :
Editorial
MeSH Terms :
Clinical Decision-Making*
Evidence-Based Medicine*
Iodine Radioisotopes/*therapeutic use
Neck/*diagnostic imaging
Thyroglobulin/*blood
Thyroid Neoplasms/*radiotherapy
Humans ; Postoperative Period ; Thyroid Neoplasms/blood ; Thyroid Neoplasms/diagnostic imaging ; Thyroid Neoplasms/surgery ; Ultrasonography
Opinia redakcyjna
Tytuł :
Delivering PET imaging results to cancer patients: steps for handling ethical issues.
Autorzy :
Gonzalez S; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Timone University Hospital, Marseille, France. .; CERIMED, Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France. .
Guedj E; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Timone University Hospital, Marseille, France.; CERIMED, Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.; Aix-Marseille Université, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France.
Fanti S; Medicina Nucleare, Policlinico S. Orsola, Università di Bologna, Bologna, Italy.
Lalumera E; Psychology Department & Philosophy of Health and Disease Research Center, Milano-Bicocca University, Milan, Italy.
Le Coz P; UMR 7268 ADéS, Espace Ethique Méditerranéen, Timone University Hospital, Aix-Marseille University-EFS-CNRS, 13385, Marseille, France.
Taïeb D; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Timone University Hospital, Marseille, France. david.taieb@ap-hm.fr.; CERIMED, Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Nov; Vol. 45 (12), pp. 2240-2241. Date of Electronic Publication: 2018 Aug 14.
Typ publikacji :
Letter
MeSH Terms :
Communication*
Ethics, Medical*
Neoplasms/*diagnostic imaging
Positron-Emission Tomography/*ethics
Humans
Opinia redakcyjna
Tytuł :
Superiority of F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population.
Autorzy :
Jha A; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1E-3140, Bethesda, MD, 20892, USA.
Ling A; Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, National Institutes of Health, 10 Center Dr., Bldg. 10, Bethesda, MD, 20892, USA.
Millo C; Positron Emission Tomography Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1C-401 and 490, Bethesda, MD, 20892, USA.
Gupta G; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1E-3140, Bethesda, MD, 20892, USA.
Viana B; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1E-3140, Bethesda, MD, 20892, USA.
Lin FI; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr., Bldg. 10, Room B3B69F, Bethesda, MD, 20892, USA.
Herscovitch P; Positron Emission Tomography Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1C-401 and 490, Bethesda, MD, 20892, USA.
Adams KT; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1E-3140, Bethesda, MD, 20892, USA.
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Metwalli AR; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bldg. 10, Room 2 W-5940 and Room 1-5940, 10 Center Drive, Bethesda, MD, 20892, USA.
Linehan WM; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bldg. 10, Room 2 W-5940 and Room 1-5940, 10 Center Drive, Bethesda, MD, 20892, USA.
Brofferio A; Cardiovascular & Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 5-3130, Bethesda, MD, 20892, USA.
Stratakis CA; Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 31, Room 2A46 and Bldg. 10, Room 2-5142, Bethesda, MD, 20892, USA.
Kebebew E; Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Dr., Bldg. 10, Room 4-5952, Bethesda, MD, 20892, USA.
Lodish M; Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 31, Room 2A46 and Bldg. 10, Room 2-5142, Bethesda, MD, 20892, USA.
Civelek AC; Nuclear Medicine Division, Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1C-455, Bethesda, MD, 20892, USA.
Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Dr., Bldg. 10, Room 1E-3140, Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 May; Vol. 45 (5), pp. 787-797. Date of Electronic Publication: 2017 Dec 04.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
Organometallic Compounds*
Positron Emission Tomography Computed Tomography*
Paraganglioma/*genetics
Pheochromocytoma/*genetics
Succinate Dehydrogenase/*genetics
Adolescent ; Child ; Female ; Fluorodeoxyglucose F18 ; Humans ; Male ; Paraganglioma/diagnostic imaging ; Pheochromocytoma/diagnostic imaging ; Positron-Emission Tomography ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.
Autorzy :
Imperiale A; Biophysics and Nuclear Medicine, Strasbourg University Hospitals, ICube, UMR7357 University of Strasbourg/CNRS and FMTS, Strasbourg, France. .; Service de Biophysique et Médecine Nucléaire, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, 1, Avenue de Molière, 67098, Strasbourg Cedex 09, France. .
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Hindié E; Department of Nuclear Medicine, Bordeaux University Hospitals, LabEx TRAIL, University of Bordeaux, Haut-Lévêque Hospital, 33604, Pessac, France.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Apr; Vol. 45 (4), pp. 654-657.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Hyperparathyroidism, Primary*
Positron Emission Tomography Computed Tomography*
Choline/analogs & derivatives ; Humans ; Positron-Emission Tomography ; Tomography, X-Ray Computed
Opinia redakcyjna
Tytuł :
Quantitative F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype.
Autorzy :
Amodru V; Department of Endocrinology, Conception University Hospital, Aix-Marseille University, Marseille, France.
Guerin C; Department of Endocrine Surgery, Conception University Hospital, Aix-Marseille University, Marseille, France.
Delcourt S; Department of Nuclear Medicine, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, 264, rue Saint-Pierre, 13385, Marseille, France.
Romanet P; Laboratory of Molecular Biology, Conception Hospital & CNRS, CRN2M UMR 7286, Aix-Marseille University, Marseille, France.
Loundou A; Department of Public Health, EA3279 Self-perceived Health Assessment Research Unit, La Timone University, Aix-Marseille University, Marseille, France.
Viana B; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, MD, USA.
Brue T; Department of Endocrinology, Conception University Hospital, Aix-Marseille University, Marseille, France.
Castinetti F; Department of Endocrinology, Conception University Hospital, Aix-Marseille University, Marseille, France.
Sebag F; Department of Endocrine Surgery, Conception University Hospital, Aix-Marseille University, Marseille, France.
Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, MD, USA.
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, 264, rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Feb; Vol. 45 (2), pp. 278-282. Date of Electronic Publication: 2017 Sep 16.
Typ publikacji :
Journal Article
MeSH Terms :
Phenotype*
Positron Emission Tomography Computed Tomography*
Adrenal Gland Neoplasms/*diagnostic imaging
Adrenal Gland Neoplasms/*metabolism
Dihydroxyphenylalanine/*analogs & derivatives
Pheochromocytoma/*diagnostic imaging
Pheochromocytoma/*metabolism
Biological Transport ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?
Autorzy :
Verger A; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France. .; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, Nancy, France. .; IADI, INSERM, UMR 947, Lorraine University, Service de Médecine Nucléaire, rue du Morvan, 54500, Vandoeuvre-les, Nancy, France. .
Taieb D; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France.; CERIMED, Aix-Marseille Université, Marseille, France.
Guedj E; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France.; CERIMED, Aix-Marseille Université, Marseille, France.; Institut de Neurosciences de la Timone, UMR 7289, CNRS Aix-Marseille Université, Marseille, France.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Aug; Vol. 44 (8), pp. 1408-1410. Date of Electronic Publication: 2017 Apr 27.
Typ publikacji :
Letter; Comment
MeSH Terms :
Glioma*
Radiopharmaceuticals*
Amino Acids ; Brain Neoplasms ; Positron-Emission Tomography
Opinia redakcyjna
Tytuł :
IDH mutation is paradoxically associated with higher F-FDOPA PET uptake in diffuse grade II and grade III gliomas.
Autorzy :
Verger A; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France.; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, Nancy, France.; IADI, INSERM, UMR 947, Lorraine University, Nancy, France.
Metellus P; Department of Neurosurgery, Centre Hospitalier Privé Clairval, Marseille, France.; INSERM, UMR 911, Aix-Marseille University, Marseille, France.
Sala Q; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France.
Colin C; INSERM, UMR 911, Aix-Marseille University, Marseille, France.
Bialecki E; Department of Neurosurgery, Centre Hospitalier Privé Clairval, Marseille, France.
Taieb D; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France.; CERIMED, Aix-Marseille University , Marseille, France.
Chinot O; INSERM, UMR 911, Aix-Marseille University, Marseille, France.; Department of Neuro-Oncology, APHM, La Timone Hospital, Marseille, France.
Figarella-Branger D; INSERM, UMR 911, Aix-Marseille University, Marseille, France.; Department of Anatomopathology, APHM, La Timone Hospital, Marseille, France.
Guedj E; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France. .; CERIMED, Aix-Marseille University , Marseille, France. .; Institut de Neurosciences de la Timone, CNRS, UMR 7289, Aix-Marseille University, Marseille, France. .; Service Central de Biophysique et Médecine Nucléaire, Hôpital de la Timone, 264 rue Saint Pierre, 13005, Marseille, France. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Aug; Vol. 44 (8), pp. 1306-1311. Date of Electronic Publication: 2017 Mar 14.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
Positron-Emission Tomography*
Dihydroxyphenylalanine/*analogs & derivatives
Glioma/*metabolism
Glioma/*pathology
Isocitrate Dehydrogenase/*genetics
Adult ; Biological Transport ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/genetics ; Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Dihydroxyphenylalanine/metabolism ; Female ; Glioma/diagnostic imaging ; Glioma/genetics ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option.
Autorzy :
Clerc J; Department of Nuclear Medicine, Cochin University Hospital, Paris 5 René Descartes University, Paris, France.
Verburg FA; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
Avram AM; Nuclear Medicine/Radiology, University of Michigan, Ann Arbor, USA.
Giovanella L; Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Hindié E; Nuclear Medicine, Haut-Lévêque University Hospital, Bordeaux, France.
Taïeb D; Department of Nuclear Medicine, European Center for Research in Medical Imaging, La Timone University Hospital, Aix-Marseille University, 264 rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Jun; Vol. 44 (6), pp. 918-925.
Typ publikacji :
Editorial
MeSH Terms :
Iodine Radioisotopes/*therapeutic use
Thyroid Neoplasms/*radiotherapy
Thyroid Neoplasms/*surgery
Decision Making ; Humans ; Iodine Radioisotopes/administration & dosage ; Postoperative Period ; Risk Assessment ; Thyroglobulin/metabolism ; Thyroid Neoplasms/metabolism ; Thyroid Neoplasms/pathology
Opinia redakcyjna
Tytuł :
Head-to-head comparison between F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas.
Autorzy :
Heimburger C; Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.; ICube, UMR 7357, CNRS/University of Strasbourg, Strasbourg, France.; FMTS, Faculty of Medicine, University of Strasbourg, Strasbourg, France.
Veillon F; Department of Radiology, University Hospitals of Strasbourg, Strasbourg, France.
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.; Inserm UMR1068 Marseille Cancerology Research Center, Institut Paoli-Calmettes, Marseille, France.
Goichot B; Department of Internal Medicine, University Hospitals of Strasbourg, Strasbourg, France.
Riehm S; Department of Radiology, University Hospitals of Strasbourg, Strasbourg, France.
Petit-Thomas J; Department of Otolaryngology and Maxillofacial Surgery, University Hospitals of Strasbourg, Strasbourg, France.
Averous G; Department of Pathology, University Hospitals of Strasbourg, Strasbourg, France.
Cavalcanti M; Department of Radiology, University Hospitals of Strasbourg, Strasbourg, France.
Hubelé F; Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.; ICube, UMR 7357, CNRS/University of Strasbourg, Strasbourg, France.; FMTS, Faculty of Medicine, University of Strasbourg, Strasbourg, France.
Chabrier G; Department of Internal Medicine, University Hospitals of Strasbourg, Strasbourg, France.
Namer IJ; Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.; ICube, UMR 7357, CNRS/University of Strasbourg, Strasbourg, France.; FMTS, Faculty of Medicine, University of Strasbourg, Strasbourg, France.
Charpiot A; Department of Otolaryngology and Maxillofacial Surgery, University Hospitals of Strasbourg, Strasbourg, France.
Imperiale A; Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France. .; ICube, UMR 7357, CNRS/University of Strasbourg, Strasbourg, France. .; FMTS, Faculty of Medicine, University of Strasbourg, Strasbourg, France. .; Biophysics and Nuclear Medicine, Hautepierre University Hospital, 1, Avenue Molière, 67098, Strasbourg Cedex, France. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Jun; Vol. 44 (6), pp. 979-987. Date of Electronic Publication: 2017 Jan 03.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Computed Tomography Angiography*
Magnetic Resonance Imaging*
Positron Emission Tomography Computed Tomography*
Dihydroxyphenylalanine/*analogs & derivatives
Head and Neck Neoplasms/*diagnostic imaging
Paraganglioma/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Biological Transport ; Dihydroxyphenylalanine/metabolism ; Female ; Head and Neck Neoplasms/metabolism ; Humans ; Male ; Middle Aged ; Observer Variation ; Paraganglioma/metabolism ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Tytuł :
F-fluorodihydroxyphenylalanine PET/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L.
Autorzy :
Feral CC; INSERM U1081, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.
Tissot FS; INSERM U1081, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.
Tosello L; INSERM U1081, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.
Fakhry N; Department of Otorhinolaryngology-Head and Neck Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Sebag F; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, MD, 20892, USA.
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 May; Vol. 44 (5), pp. 812-821. Date of Electronic Publication: 2016 Nov 29.
Typ publikacji :
Journal Article
MeSH Terms :
Genotype*
Positron Emission Tomography Computed Tomography*
Adrenal Gland Neoplasms/*diagnostic imaging
Amino Acid Transport System L/*genetics
Dihydroxyphenylalanine/*analogs & derivatives
Paraganglioma/*diagnostic imaging
Pheochromocytoma/*diagnostic imaging
Adrenal Gland Neoplasms/genetics ; Aged ; False Negative Reactions ; Female ; Fusion Regulatory Protein 1, Heavy Chain/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Mutation ; Paraganglioma/genetics ; Pheochromocytoma/genetics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Succinate Dehydrogenase/genetics
Czasopismo naukowe
Tytuł :
PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Autorzy :
Janssen I; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA.; Department of Radiology and Nuclear Medicine, Section of Nuclear Medicine, University Hospital Schleswig Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Chen CC; Nuclear Medicine Division, Radiology & Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, 20892, USA.
Millo CM; Positron Emission Tomography Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Ling A; Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, 20892, USA.
Taieb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Lin FI; Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Adams KT; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA.
Wolf KI; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA.
Herscovitch P; Positron Emission Tomography Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Fojo AT; Endocrine Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Buchmann I; Department of Radiology and Nuclear Medicine, Section of Nuclear Medicine, University Hospital Schleswig Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Kebebew E; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Pacak K; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2016 Sep; Vol. 43 (10), pp. 1784-91. Date of Electronic Publication: 2016 Mar 21.
Typ publikacji :
Journal Article
MeSH Terms :
Organometallic Compounds*
Magnetic Resonance Imaging/*methods
Paraganglioma/*diagnostic imaging
Paraganglioma/*secondary
Positron Emission Tomography Computed Tomography/*methods
Tomography, X-Ray Computed/*methods
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Radiopharmaceuticals ; Reproducibility of Results ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Autorzy :
Archier A; Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.; Institut Paoli-Calmettes, Inserm UMR1068 Marseille Cancerology Research Center, Marseille, France.
Varoquaux A; Department of Medical Imaging, Conception Hospital, Aix-Marseille University, Marseille, France.
Garrigue P; Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.; Department of Radiopharmacy, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.
Montava M; Department of Otorhinolaryngology-Head and Neck Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Guerin C; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Gabriel S; Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.
Beschmout E; Department of Medical Imaging, Conception Hospital, Aix-Marseille University, Marseille, France.
Morange I; Department of Endocrinology, Conception Hospital, Aix-Marseille University, Marseille, France.
Fakhry N; Department of Otorhinolaryngology-Head and Neck Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Castinetti F; Department of Endocrinology, Conception Hospital, Aix-Marseille University, Marseille, France.
Sebag F; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Barlier A; Laboratory of Biochemistry and Molecular Biology, Conception Hospital, Aix-Marseille, University, Marseille, France.
Loundou A; Department of Public Health, Aix-Marseille University, Marseille, France.
Guillet B; Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.; Department of Radiopharmacy, La Timone & North University Hospital, Aix-Marseille University, Marseille, France.
Pacak K; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health, Bethesda, MD, 20892, USA.
Taïeb D; Department of Nuclear Medicine, La Timone & North University Hospital, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.; Institut Paoli-Calmettes, Inserm UMR1068 Marseille Cancerology Research Center, Marseille, France. david.taieb@ap-hm.fr.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2016 Jul; Vol. 43 (7), pp. 1248-57. Date of Electronic Publication: 2015 Dec 05.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article
MeSH Terms :
Organometallic Compounds*
Adrenal Gland Neoplasms/*diagnostic imaging
Dihydroxyphenylalanine/*analogs & derivatives
Paraganglioma/*diagnostic imaging
Pheochromocytoma/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Adult ; Aged ; Aged, 80 and over ; False Positive Reactions ; Female ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
Autorzy :
Archier A; Department of Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.
Heimburger C; Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.
Guerin C; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Morange I; Department of Endocrinology, Conception Hospital, Aix-Marseille University, Marseille, France.
Palazzo FF; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Henry JF; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Schneegans O; Department of Nuclear Medicine, Paul Strauss Cancer Center, Strasbourg, France.
Mundler O; Department of Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.
Abdullah AE; Department of Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Sebag F; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France.
Imperiale A; Department of Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.; Faculty of Medicine, ICube, UMR 7357 University of Strasbourg/CNRS and FMTS, Strasbourg, France.
Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.; Inserm UMR1068 Marseille Cancerology Research Center, Institut Paoli-Calmettes, Marseille, France. david.taieb@ap-hm.fr.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2016 Jun; Vol. 43 (6), pp. 1027-33. Date of Electronic Publication: 2015 Oct 24.
Typ publikacji :
Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Carcinoma, Neuroendocrine/*diagnostic imaging
Dihydroxyphenylalanine/*analogs & derivatives
Thyroid Neoplasms/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Calcitonin/metabolism ; Carcinoma, Neuroendocrine/metabolism ; Carcinoma, Neuroendocrine/pathology ; Female ; Humans ; Middle Aged ; Prognosis ; Retrospective Studies ; Thyroid Neoplasms/metabolism ; Thyroid Neoplasms/pathology ; Young Adult
SCR Disease Name :
Thyroid cancer, medullary
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies